95 related articles for article (PubMed ID: 3260465)
1. [Growth factors as biological markers of malignancy].
Tahara E; Yokozaki H
Gan To Kagaku Ryoho; 1988 Apr; 15(4 Pt 2-1):1102-8. PubMed ID: 3260465
[TBL] [Abstract][Full Text] [Related]
2. Immunohistochemical study of oncogene product ras p21, c-myc and growth factor EGF in breast carcinomas.
Mizukami Y; Nonomura A; Noguchi M; Taniya T; Koyasaki N; Saito Y; Hashimoto T; Matsubara F; Yanaihara N
Anticancer Res; 1991; 11(4):1485-94. PubMed ID: 1660689
[TBL] [Abstract][Full Text] [Related]
3. Interaction between transforming growth factor-alpha and c-Ha-ras p21 in progression of human gastric carcinoma.
Yamamoto T; Hattori T; Tahara E
Pathol Res Pract; 1988 Nov; 183(6):663-9. PubMed ID: 3065747
[TBL] [Abstract][Full Text] [Related]
4. Epidermal growth factor receptor and transforming growth factor alpha expression in papillary and nonpapillary renal cell carcinoma: correlation with metastatic behavior and prognosis.
Uhlman DL; Nguyen P; Manivel JC; Zhang G; Hagen K; Fraley E; Aeppli D; Niehans GA
Clin Cancer Res; 1995 Aug; 1(8):913-20. PubMed ID: 9816062
[TBL] [Abstract][Full Text] [Related]
5. Human lung cancers growing on extracellular matrix: expression of oncogenes and growth factors.
Pavelic K; Antonic M; Pavelic L; Pavelic J; Pavelic Z; Spaventi S
Anticancer Res; 1992; 12(6B):2191-6. PubMed ID: 1363516
[TBL] [Abstract][Full Text] [Related]
6. Loss of growth responsiveness to epidermal growth factor and enhanced production of alpha-transforming growth factors in ras-transformed mouse mammary epithelial cells.
Salomon DS; Perroteau I; Kidwell WR; Tam J; Derynck R
J Cell Physiol; 1987 Mar; 130(3):397-409. PubMed ID: 3494020
[TBL] [Abstract][Full Text] [Related]
7. A subclass of HER1 ligands are prognostic markers for survival in bladder cancer patients.
Thøgersen VB; Sørensen BS; Poulsen SS; Orntoft TF; Wolf H; Nexo E
Cancer Res; 2001 Aug; 61(16):6227-33. PubMed ID: 11507076
[TBL] [Abstract][Full Text] [Related]
8. Ha-ras oncogene product in human gastric carcinoma: correlation with invasiveness, metastasis or prognosis.
Tahara E; Yasui W; Taniyama K; Ochiai A; Yamamoto T; Nakajo S; Yamamoto M
Jpn J Cancer Res; 1986 Jun; 77(6):517-22. PubMed ID: 3089984
[TBL] [Abstract][Full Text] [Related]
9. Mucosal thickening adjacent to gastric malignancy: association with epidermal growth factor.
Lee EY; Wang TC; Clouse RE; DeSchryver-Kecskemeti K
Mod Pathol; 1989 Jul; 2(4):397-402. PubMed ID: 2788275
[TBL] [Abstract][Full Text] [Related]
10. Differential expression of the epidermal growth factor receptor and its ligands in primary non-small cell lung cancers and adjacent benign lung.
Rusch V; Baselga J; Cordon-Cardo C; Orazem J; Zaman M; Hoda S; McIntosh J; Kurie J; Dmitrovsky E
Cancer Res; 1993 May; 53(10 Suppl):2379-85. PubMed ID: 7683573
[TBL] [Abstract][Full Text] [Related]
11. Immunoreactive alpha transforming growth factor activity in effusions from cancer patients as a marker of tumor burden and patient prognosis.
Arteaga CL; Hanauske AR; Clark GM; Osborne CK; Hazarika P; Pardue RL; Tio F; Von Hoff DD
Cancer Res; 1988 Sep; 48(17):5023-8. PubMed ID: 3165707
[TBL] [Abstract][Full Text] [Related]
12. Growth factors and oncogenes in human gastrointestinal carcinomas.
Tahara E
J Cancer Res Clin Oncol; 1990; 116(2):121-31. PubMed ID: 2157713
[TBL] [Abstract][Full Text] [Related]
13. Significance of tyrosine kinase activity on malign transformation of ovarian tumors: a comparison between EGF-R and TGF-alpha.
Zeren T; Inan S; Seda Vatansever H; Ekerbicer N; Sayhan S
Acta Histochem; 2008; 110(3):256-63. PubMed ID: 18054376
[TBL] [Abstract][Full Text] [Related]
14. Transforming growth factor alpha, epidermal growth factor, and epidermal growth factor receptor expression in normal and diseased human adrenal cortex by immunohistochemistry and in situ hybridization.
Sasano H; Suzuki T; Shizawa S; Kato K; Nagura H
Mod Pathol; 1994 Sep; 7(7):741-6. PubMed ID: 7824507
[TBL] [Abstract][Full Text] [Related]
15. Smad7 but not Smad6 cooperates with oncogenic ras to cause malignant conversion in a mouse model for squamous cell carcinoma.
Liu X; Lee J; Cooley M; Bhogte E; Hartley S; Glick A
Cancer Res; 2003 Nov; 63(22):7760-8. PubMed ID: 14633701
[TBL] [Abstract][Full Text] [Related]
16. Identification of transforming growth factor alpha in human primary breast carcinomas.
Macias A; Perez R; Hägerström T; Skoog L
Anticancer Res; 1987; 7(6):1271-5. PubMed ID: 3502066
[TBL] [Abstract][Full Text] [Related]
17. Growth factors and oncogene products in transitional cell carcinoma.
Nakanishi K; Kawai T; Suzuki M; Torikata C
Mod Pathol; 1996 Mar; 9(3):292-7. PubMed ID: 8685230
[TBL] [Abstract][Full Text] [Related]
18. Detection of epidermal growth factor and transforming growth factor alpha protein in meningiomas and other tumors of the central nervous system in human beings.
Sanfilippo JS; Rao CV; Guarnaschelli JJ; Woost PG; Byrd VM; Jones E; Schultz GS
Surg Gynecol Obstet; 1993 Nov; 177(5):488-96. PubMed ID: 8211601
[TBL] [Abstract][Full Text] [Related]
19. [Human epidermal growth factor (h-EGF) in gastric carcinomas].
Fushida S; Yonemura Y; Sugiyama K; Matsumoto H; Kamata T; Miwa K; Miyazaki I
Nihon Geka Gakkai Zasshi; 1988 Dec; 89(12):1965-8. PubMed ID: 3265984
[TBL] [Abstract][Full Text] [Related]
20. Transforming growth factor-alpha, epidermal growth factor receptor, and MiB-1 expression in Barrett's-associated neoplasia: correlation with prognosis.
Yacoub L; Goldman H; Odze RD
Mod Pathol; 1997 Feb; 10(2):105-12. PubMed ID: 9127315
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
